Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,340,863
-
Share change
-
-785,329
-
Total reported value
-
$77,465,816
-
Put/Call ratio
-
0%
-
Price per share
-
$1.48
-
Number of holders
-
95
-
Value change
-
-$4,311,446
-
Number of buys
-
42
-
Number of sells
-
54
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q1 2020
As of 31 Mar 2020 CYMABAY THERAPEUTICS INC - COM (CBAY) had 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,340,863 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Avoro Capital Advisors LLC, VANGUARD GROUP INC, DEUTSCHE BANK AG\, Redmile Group, LLC, CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., Ikarian Capital, LLC, BOXER CAPITAL, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 95 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.